Rupesh Bajpai
About Rupesh Bajpai
Rupesh Bajpai serves as the Senior Strategic Account Director for Global Commercials in the Enterprise Business sector at ArisGlobal. He has extensive experience in business development and clinical research, having held various roles in prominent organizations and possessing a strong background in safety writing and technology applications in healthcare.
Current Role at ArisGlobal
Rupesh Bajpai serves as the Senior Strategic Account Director for Global Commercials in the Enterprise Business at ArisGlobal. He has held this position since 2022, operating out of the Princeton Area in the United States. In this role, he engages with C-suite executives and corporate leadership to drive business transformation within top 50 Biopharmas and Health Agencies.
Previous Experience in Business Development
Prior to his current role, Rupesh Bajpai worked at Karmic Lifesciences LLP in various capacities, including Sr. Manager of Business Development (US) from 2012 to 2013 and Manager of Business Development from 2011 to 2012. He also held the position of Sr. Executive in Business Development for a brief period in 2009. His experience spans over several years in business development roles, contributing to his expertise in the industry.
Experience at Indegene
Rupesh Bajpai was employed at Indegene as Sr. Account Director for Global Business Development from 2013 to 2020. During his seven years in this role, he operated in the Greater New York City Area, where he focused on developing global business strategies and managing key accounts.
Educational Background
Rupesh Bajpai holds a Master of Science in Clinical Research from Cranfield University, where he studied from 2007 to 2009. He also completed a Post Graduate Diploma in Pharmaceutical Management at the Institute of Clinical Research in India during the same period. Earlier, he earned a Bachelor of Science degree in Biotechnology, Genetics, and Biochemistry from Bangalore University from 2004 to 2007.
Expertise in Clinical and Regulatory Processes
Rupesh Bajpai possesses significant experience in safety writing, including Risk Management Plans (RMP), Risk Evaluation and Mitigation Strategies (REMS), and Periodic Benefit-Risk Evaluation Reports (PBRER/PSUR). He has a comprehensive understanding of the entire clinical trial process from Phase I to Phase IV, encompassing data management and medical writing. His expertise also includes the application of AI/ML, NLP/NLG, and RPA technologies in various healthcare contexts.